Tag: US drug maker
It’s a no go – Pfizer and Allergan will not merge
Last November, global biopharmaceutical giant Pfizer and Botox maker Allergan announced an all-stock $160 billion merger that would have resulted in the creation of...
Pfizer, Allergan merger to create the world’s biggest pharmaceutical company
Global biopharmaceutical giant Pfizer and Botox maker Allergan have announced an all-stock $160 billion merger that will result in the creation of the world’s...
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
